VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March
VistaGen Therapeutics (NASDAQ: VTGN) announced participation in two investor conferences in March.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
VistaGen Therapeutics (NASDAQ: VTGN) announced participation in two investor conferences in March. The first is the Maxim Group and M-Vest’s Inaugural Emerging Growth Virtual Conference from March 17-19, featuring a corporate presentation and a fireside chat on March 19 at 1:00 p.m. ET. The second conference, the Benzinga Biotech Small Cap Conference, is on March 25 at 10:05 a.m. ET. VistaGen aims to develop innovative treatments for anxiety, depression, and central nervous system disorders. More details can be found on the respective conference websites.
Details
News Market Reaction – VTGN
The recorded move for VTGN in the trading session of this news was +0.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that Shawn Singh, VistaGen’s Chief Executive Officer, will participate in the following investor conferences in March:
| Maxim Group and M-Vest’s Inaugural Emerging Growth Virtual Conference | |
| Dates: | March 17th – 19th |
| Format: | Corporate Presentation & One-on-One Fireside Chat |
| Date: | Friday, March 19th at 1:00 p.m. ET |
| Format: | Fireside Chat with Jason McCarthy, Research Analyst |
| Website: | To attend the virtual conference, register here |
| https://www.m-vest.com/events/2021-emerging-growth-virtual-conference | |
| Benzinga Biotech Small Cap Conference | |
| Date: | Thursday, March 25th at 10:05 a.m. ET |
| Format: | Corporate Presentation |
| Website: | To attend the virtual conference, register here |
| https://events.benzinga.com/registration-page16068526119171607978331877 | |
For more information regarding the conferences, please visit the sponsor conference websites.
About VistaGen
VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets. For more information, please visit www.vistagen.com and connect with VistaGen on Twitter, LinkedIn, and Facebook.
Company Contact
Mark A. McPartland
VistaGen Therapeutics, Inc.
Phone: +1 (650) 577-3600
Email: IR@vistagen.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.